GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,456.00p
   
  • Change Today:
      9.50p
  • 52 Week High: 1,766.50
  • 52 Week Low: 1,264.00
  • Currency: UK Pounds
  • Shares Issued: 4,099.17m
  • Volume: 6,678,890
  • Market Cap: £59,684m
  • RiskGrade: 129
  • Beta: 0.00

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
30-Apr-25 Shore Capital Buy 1,483.50p - - Reiteration
28-Mar-25 JP Morgan Cazenove Underweight 1,488.50p - - Reiteration
29-Nov-24 Berenberg Bank Buy 1,335.00p 1,820.00p 1,600.00p Reiteration
03-Sep-24 Deutsche Buy 1,655.00p - 1,850.00p Reiteration
05-Jul-24 Citigroup Buy 1,511.00p 2,120.00p 1,900.00p Reiteration
27-Jun-24 Jefferies Buy 1,526.00p - 2,100.00p Reiteration
07-May-24 Barclays Equal-weight 1,761.00p - 1,725.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

GSK Market Data

Currency UK Pounds
Share Price 1,456.00p
Change Today 9.50p
% Change 0.66 %
52 Week High 1,766.50
52 Week Low 1,264.00
Volume 6,678,890
Shares Issued 4,099.17m
Market Cap £59,684m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average45.42% below the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Price Trend
18.04% above the market average18.04% above the market average18.04% above the market average18.04% above the market average18.04% above the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Income
74.28% above the market average74.28% above the market average74.28% above the market average74.28% above the market average74.28% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
36.99% below the market average36.99% below the market average36.99% below the market average36.99% below the market average36.99% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 14
Sell 3
Strong Sell 1
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 29-May-2025

Time Volume / Share Price
15:16 1 @ 1,458.50p
14:50 0 @ 1,451.00p
16:36 24,159 @ 1,456.00p
16:35 19,265 @ 1,456.00p
16:35 68 @ 1,456.00p

GSK Key Personnel

CEO Emma Walmsley

Top of Page